Inhaled corticosteroids list
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest that inhaled corticosteroids effectively control asthma symptoms, improve lung function, and reduce exacerbations, but their effectiveness in COPD is more controversial and may lead to side effects like oropharyngeal candidiasis and lower cortisol levels.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Comprehensive List of Inhaled Corticosteroids
Inhaled corticosteroids (ICS) are a cornerstone in the management of various respiratory conditions, particularly asthma and chronic obstructive pulmonary disease (COPD). They are favored for their potent anti-inflammatory properties and minimal systemic side effects when used at appropriate doses. Below is a detailed overview of the most commonly used inhaled corticosteroids, their applications, and their comparative efficacy.
Common Inhaled Corticosteroids for Asthma and COPD
Beclometasone Dipropionate
Beclometasone dipropionate is widely used in the treatment of asthma. It is effective in reducing inflammation and controlling asthma symptoms. Studies have shown that beclometasone, when used at low to medium doses, provides significant benefits in managing asthma with minimal side effects .
Budesonide
Budesonide is another commonly prescribed ICS for both asthma and COPD. It has been shown to improve lung function, reduce symptoms, and enhance the quality of life in patients with these conditions. Budesonide is often compared with other ICS like fluticasone, and it has been found to be effective, although it may have a slightly higher impact on growth in children .
Fluticasone Propionate
Fluticasone propionate is frequently used due to its high potency and effectiveness in controlling asthma symptoms. It is often preferred for its relatively lower impact on growth in children compared to other ICS like beclometasone and budesonide. Fluticasone is also used in combination with long-acting beta2-agonists (LABAs) to enhance asthma control .
Mometasone Furoate
Mometasone furoate is another potent ICS used in the management of asthma. It is known for its strong anti-inflammatory effects and is often used in combination inhalers with LABAs to improve patient compliance and control asthma at lower doses of corticosteroids .
Ciclesonide
Ciclesonide is a prodrug that is activated in the lungs, which helps to minimize systemic side effects. It is used in the treatment of asthma and has been shown to be effective in reducing airway inflammation and improving lung function.
Efficacy and Safety in Different Conditions
Asthma
ICS are the first-line therapy for persistent asthma across all age groups. They are effective in controlling symptoms, improving lung function, and preventing exacerbations. The addition of LABAs to ICS therapy has been shown to further improve asthma control and reduce the required dose of corticosteroids .
Chronic Obstructive Pulmonary Disease (COPD)
The role of ICS in COPD is more controversial. While they do not alter the progression of the disease, ICS can reduce the frequency of exacerbations and improve the quality of life in patients with severe COPD. However, their use is associated with an increased risk of pneumonia, and they are often combined with bronchodilators for better management of symptoms .
Bronchopulmonary Dysplasia (BPD)
Inhaled corticosteroids are also used in the management of bronchopulmonary dysplasia in preterm infants. Studies have shown that early administration of ICS can reduce the incidence of chronic lung disease and mortality in very low birth weight preterm neonates, although the long-term benefits and risks are still being evaluated .
Conclusion
Inhaled corticosteroids are a critical component in the management of asthma and COPD, offering significant benefits in controlling inflammation and improving patient outcomes. The choice of ICS and the delivery device can impact the efficacy and safety profile, particularly in children. Ongoing research continues to refine the use of these medications to maximize their benefits while minimizing potential risks.
Sources and full results
Most relevant research papers on this topic
